Jeffrey L. Wong
Memorial Sloan Kettering Cancer Center(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction, Immunotherapy and Immune Responses, Immune cells in cancer, Bladder and Urothelial Cancer Treatments
Most-Cited Works
- → PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation(2019)178 cited
- → IL-18–Primed Helper NK Cells Collaborate with Dendritic Cells to Promote Recruitment of Effector CD8+ T Cells to the Tumor Microenvironment(2013)145 cited
- → PGE2-Driven Induction and Maintenance of Cancer-Associated Myeloid-Derived Suppressor Cells(2012)139 cited
- → A Multi-Stakeholder Perspective on the Use of Alternative Test Strategies for Nanomaterial Safety Assessment(2013)114 cited
- → Induction and stability of human Th17 cells require endogenous NOS2 and cGMP-dependent NO signaling(2013)112 cited
- → PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine(2022)75 cited
- → Dendritic cell targeting with Fc-enhanced CD40 antibody agonists induces durable antitumor immunity in humanized mouse models of bladder cancer(2021)74 cited
- → Synergistic COX2 Induction by IFNγ and TNFα Self-Limits Type-1 Immunity in the Human Tumor Microenvironment(2016)66 cited
- → PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation(2020)65 cited
- → Helper Activity of Natural Killer Cells During the Dendritic Cell-mediated Induction of Melanoma-specific Cytotoxic T Cells(2011)58 cited